Spondyloarthritis Clinical Trial
Official title:
Impact of Medical Education of Physician Action 2
This is a retrospective and prospective designed study, included hospitals are 1:1 assigned into two groups: ①Interventional hospital, which will receive 3-month medical education; ②Non-interventional hospital, which will not receive 3-month medical education. During 1 month before education, all the electronic records of outpatients and inpatients who visit the included rheumatologists will be collected and the data of test and evaluation results of spondyloarthritis (SpA) patients diagnosed according to new Assessment of Spondylo-Arthritis International Society (ASAS) criteria will be collected from outpatient electronic records and inpatients medical charts; in the 3 months after education, the same data will be collected and compared with the data before education, and the impact of medical education on physician behaviour will be analyzed. Meanwhile, the understanding and acceptance level will be evaluated by the questionnaire, the differences before and after education and the impact of education on physician cognition will be evaluated.
Status | Not yet recruiting |
Enrollment | 30 |
Est. completion date | December 2016 |
Est. primary completion date | September 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Interventional hospital will be selected based on following criteria: 1. having complete outpatients and inpatients electronic records; 2. more than 50% of registrars and/or consultants in the department participated the professional education event; 3. the department head is willing to participate the clinical audit and provide the information from outpatients and inpatients records for data collection; 4. except for rheumatic diseases have been clearly diagnosed. Non-interventional hospital will be selected based on following criteria: 1. having complete outpatients and inpatients electronic records; 2. no professional education event covered; 3. the department head is willing to participate the clinical audit and provide the information from outpatients and inpatients records for data collection; 4. except for rheumatic diseases have been clearly diagnosed. |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
China | Shanxi Dayi Hospital | Taiyuan | Shanxi |
Lead Sponsor | Collaborator |
---|---|
Shanxi Dayi Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean of number of positive SpA feature of newly diagnosed patients with inflammatory back pain, before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Primary | Proportion of patients with a image examination of sacroiliitis ( x-rays, CT, or MRI) in the audit period, before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Primary | Proportion of patients with a assessment of disease activity in the audit period, before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Secondary | Proportion of patients with a clear diagnosis (Diagnostic for Spondyloarthritis with new ASAS criteria) or receiving a new diagnosis in the audit period, before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Secondary | Mean of the number of physical examinations of disease activity in the audit period, before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Secondary | Change of questionnaire scores of physician in the audit period, before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Secondary | Change of utilization rate of Non Steroidal Anti Inflammatory Drugs (NSAIDs) before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No | |
Secondary | Change of utilization rate of biological medication before and after the (no-)event | 1 month before (no-) education vs. 3 months after (no-) education | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03564743 -
Description of Spondylarthritis and Validation of ASAS Criteria in West Indian Patients Seen in Consultation of Rheumatology.
|
||
Completed |
NCT01219257 -
Longitudinal ULtrasonographic Study of Patients With Spondylarthritis Starting Biological Therapy
|
||
Recruiting |
NCT05433168 -
Study Evaluating the Effectiveness of Shiatsu on Fatigue in Patients With Axial Spondyloarthritis
|
N/A | |
Terminated |
NCT03232580 -
99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis
|
Phase 2 | |
Recruiting |
NCT05039216 -
Biobank for Inflammatory Chronic Diseases and Osteoporosis
|
||
Completed |
NCT04483648 -
Cervical Stabilization Exercises in Patients With Spondyloarthritis
|
N/A | |
Recruiting |
NCT04602091 -
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
|
||
Not yet recruiting |
NCT04077957 -
Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs
|
Phase 4 | |
Recruiting |
NCT05290363 -
The Role of IL-23 in Chronic Inflammatory Disease: Exploring the Cellular and Molecular Targets of IL-23 Signaling in Peripheral and Axial Spondyloarthritis
|
N/A | |
Not yet recruiting |
NCT05006690 -
Telerehabilitation, Face-to-Face and Home-Based Spinal Stabilization Exercise Training in Patients With Spondyloarthritis
|
N/A | |
Completed |
NCT02998398 -
Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
|
||
Completed |
NCT02148640 -
The NOR-SWITCH Study
|
Phase 4 | |
Completed |
NCT01174186 -
Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing
|
Phase 4 | |
Recruiting |
NCT04499001 -
Effect of Pharmaceutical Consultations Just Before Rheumatology Consultations on Improving Knowledge and Skills for Patients With Inflammatory Arthritis With Subcutaneous Biologic DMARDs
|
||
Completed |
NCT03253796 -
Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)
|
Phase 4 | |
Active, not recruiting |
NCT04169373 -
A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial Spondyloarthritis
|
Phase 3 | |
Recruiting |
NCT04292067 -
Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis
|
||
Completed |
NCT04946539 -
Value of Ultrasonographic Enthesitis Assessment in Spondyloarthritis
|
||
Recruiting |
NCT03983473 -
Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.
|
N/A | |
Terminated |
NCT03345355 -
MRI of Sacroiliac Joints: Evaluation of Accuracy of Dixon Sequences in the Diagnosis of Axial Spondyloarthritis
|